Published in Atherosclerosis on June 06, 2005
Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J (2003) 3.55
Sequence diversity in 36 candidate genes for cardiovascular disorders. Am J Hum Genet (1999) 3.02
Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension (1996) 2.44
Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology (2006) 2.11
Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse. QJM (1995) 2.09
Incidence, recurrence, and case fatality rates for myocardial infarction in southwestern France, 1985 to 1993. Heart (2000) 1.97
Increased plasma serotonin in primary pulmonary hypertension. Am J Med (1995) 1.86
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med (2002) 1.65
Menopause and modifiable coronary heart disease risk factors: a population based study. Maturitas (2009) 1.61
Leisure-time physical activity and regular walking or cycling to work are associated with adiposity and 5 y weight gain in middle-aged men: the PRIME Study. Int J Obes Relat Metab Disord (2001) 1.53
Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol (1990) 1.53
Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2005) 1.52
Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thromb Res (1991) 1.51
Sex differences in awareness and control of hypertension in France. J Hypertens (1997) 1.49
Embolic and bleeding events after modified Bentall procedure in selected patients. Heart (2006) 1.47
Validation of a live animal model for training in endoscopic hemostasis of upper gastrointestinal bleeding ulcers. Endoscopy (2013) 1.46
[Risk factors management in 5708 ambulatory patients suffering from peripheral vascular disease followed in urban practices]. Arch Mal Coeur Vaiss (2005) 1.45
Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr (1997) 1.42
Differences in use of coronary angiography and outcome of myocardial infarction in Toulouse (France) and Gerona (Spain). The MONICA-Toulouse and REGICOR investigators. Eur Heart J (2000) 1.38
Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol (2000) 1.34
Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens (2001) 1.29
Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol (2004) 1.22
Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study. Atherosclerosis (1999) 1.22
Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome. Clin Lab Haematol (2002) 1.19
Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest (1998) 1.18
Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. Hum Mol Genet (2000) 1.18
Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study. Int J Epidemiol (2001) 1.17
The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet (1998) 1.15
Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Br J Haematol (1981) 1.15
Renal vascular lesions in lupus nephritis. Medicine (Baltimore) (1997) 1.14
Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol (2000) 1.14
Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results. J Am Coll Cardiol (1997) 1.14
Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde. J Mol Med (Berl) (2001) 1.11
Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol (1995) 1.09
Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am J Pathol (1997) 1.09
Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease. Arteriosclerosis (1987) 1.09
Predicting CHD risk in France: a pooled analysis of the D.E.S.I.R., Three City, PRIME, and SU.VI.MAX studies. Eur J Cardiovasc Prev Rehabil (2011) 1.08
Different alcohol drinking and blood pressure relationships in France and Northern Ireland: The PRIME Study. Hypertension (2001) 1.08
Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury. Role of cyclic guanosine 5'-monophosphate. Am J Respir Crit Care Med (1998) 1.07
Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med (1990) 1.07
High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy. Arterioscler Thromb Vasc Biol (2000) 1.07
The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension (1999) 1.06
Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France. Acta Neurol Scand (1989) 1.06
Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": one-year results from a nationwide French survey. Circulation (1999) 1.04
Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol (1994) 1.04
New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and blood pressure: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde. J Hypertens (1998) 1.04
Incidence, case fatality, risk factors of acute coronary heart disease and occupational categories in men aged 30-59 in France. Int J Epidemiol (1997) 1.01
Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb (1994) 1.01
An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients. AIDS (2001) 0.99
The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab (2003) 0.98
[Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients]. J Mal Vasc (2010) 0.96
In vivo regulation of von willebrand factor synthesis: von Willebrand factor production in endothelial cells after lung transplantation between normal pigs and von Willebrand factor-deficient pigs. Arterioscler Thromb Vasc Biol (1999) 0.96
Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis (2005) 0.96
D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemost (1991) 0.96
Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome. J Pediatr (1987) 0.95
Sedentary behaviour, physical activity and dietary patterns are independently associated with the metabolic syndrome. Diabetes Metab (2012) 0.95
Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study. J Hum Hypertens (2010) 0.95
Depressed mood and dietary fish intake: direct relationship or indirect relationship as a result of diet and lifestyle? J Affect Disord (2007) 0.95
Platelet functions and haemostasis parameters in pigs: absence of side effects of a procedure of general anaesthesia. Thromb Res (1996) 0.95
Polymorphisms of the endothelial nitric oxide synthase gene - no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest (1999) 0.95
Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study. Arterioscler Thromb Vasc Biol (2000) 0.95
Influence of parental history of hypertension on blood pressure. J Hum Hypertens (1999) 0.95
Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb Haemost (1998) 0.94
Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy. J Clin Endocrinol Metab (2001) 0.93
Bone mineral decrease in the leg with unilateral chronic occlusive arterial disease. Clin Exp Rheumatol (2003) 0.93
Paraoxonase activity in two healthy populations with differing rates of coronary heart disease. Eur J Clin Invest (2000) 0.92
Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke. Cerebrovasc Dis (2009) 0.92
No alteration in platelet function or coagulation induced by EGb761 in a controlled study. Clin Lab Haematol (2003) 0.92
Change in cardiovascular risk factors in France, 1985-1997. Eur J Epidemiol (2004) 0.92
Serum lipids in young patients with ischaemic stroke: a case-control study. J Neurol Neurosurg Psychiatry (2000) 0.92
Eating frequency and body fatness in middle-aged men. Int J Obes Relat Metab Disord (2002) 0.92
Association between liver X receptor alpha gene polymorphisms and risk of metabolic syndrome in French populations. Int J Obes (Lond) (2008) 0.91
The North-East-South gradient of coronary heart disease mortality and case fatality rates in France is consistent with a similar gradient in risk factor clusters. Eur J Epidemiol (2000) 0.91
Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population. Arterioscler Thromb Vasc Biol (1997) 0.91
A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism. J Thromb Haemost (2010) 0.91
Anthropometric assessment of abdominal obesity and coronary heart disease risk in men: the PRIME study. Heart (2009) 0.91
Creatininuria in asthmatic children treated with a combination of glucocorticoid and beta-agonist. J Asthma (2003) 0.90
Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group. Eur Heart J (1999) 0.90
Island flaps with an exclusively venous pedicle. A report of eleven cases and a preliminary haemodynamic study. Br J Plast Surg (1987) 0.90
Variability of ankle-arm index in general population according to its mode of calculation. Int Angiol (2002) 0.90
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis. Eur Respir J (2002) 0.90
Expression of von Willebrand factor in porcine vessels: heterogeneity at the level of von Willebrand factor mRNA. J Cell Physiol (1989) 0.89
Higher mental stimulation at work is associated with improved cognitive functioning in both young and older workers. Ergonomics (2010) 0.89